Loading clinical trials...
Loading clinical trials...
The objective of this study is to identify relevant signature gene networks of cardiovascular disease in endothelial cells derived from circulating endothelial progenitor cells of individuals with established cardiovascular disease (CVD).
The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age, matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use. Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to differentiate into endothelial cells.
Age
30 - 60 years
Sex
ALL
Healthy Volunteers
Yes
Tufts Medical Center - Cardiovascular Clinic
Boston, Massachusetts, United States
Start Date
May 21, 2018
Primary Completion Date
September 23, 2021
Completion Date
September 30, 2021
Last Updated
July 28, 2021
isolation of endothelial cells precursors in blood
OTHER
Lead Sponsor
Tufts University
Collaborators
NCT06216847
NCT07149688
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06759805